{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:37:34Z","timestamp":1791974254757,"version":"4.4.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T00:00:00Z","timestamp":1484179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00018-016-2443-3","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T13:27:16Z","timestamp":1484227636000},"page":"1859-1869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cytochrome P450 2U1, a very peculiar member of the human P450s family"],"prefix":"10.1007","volume":"74","author":[{"given":"L.","family":"Dhers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ducassou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Mansuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,12]]},"reference":[{"key":"2443_CR1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-12108-6","volume-title":"Cytochrome P450: structure, mechanism and biochemistry","author":"PR Ortiz de Montellano","year":"2015","unstructured":"Ortiz de Montellano PR (2015) Cytochrome P450: structure, mechanism and biochemistry, 4th edn. Kluwer Academic\/Plenum Publishers, New York","edition":"4"},{"key":"2443_CR2","doi-asserted-by":"crossref","unstructured":"Ortiz de Montellano PR (2015) Substrate oxidation by cytochrome P450 enzymes. In: Ortiz de Montellano PR (ed) Cytochrome P450: structure, mechanism and biochemistry, 4th edn. Kluwer Academic\/Plenum Publishers, New York, pp 111\u2013176","DOI":"10.1007\/978-3-319-12108-6_4"},{"key":"2443_CR3","doi-asserted-by":"crossref","first-page":"17065","DOI":"10.1074\/jbc.R113.462275","volume":"288","author":"FP Guengerich","year":"2013","unstructured":"Guengerich FP, Munro AW (2013) Unusual cytochrome P450 enzymes and reactions. J Biol Chem 288:17065\u201317073","journal-title":"J Biol Chem"},{"key":"2443_CR4","doi-asserted-by":"crossref","unstructured":"Guengerich FP (2015) Human cytochrome P450 enzymes. In: Ortiz de Montellano PR (ed), Cytochrome P450: structure, mechanism and biochemistry, 4th edn. Kluwer Academic\/Plenum Publishers, New York, pp 523\u2013785","DOI":"10.1007\/978-3-319-12108-6_9"},{"key":"2443_CR5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/03602530701467708","volume":"39","author":"K Stark","year":"2007","unstructured":"Stark K, Guengerich FP (2007) Characterization of orphan human cytochromes P450. Drug Metab Rev 39:627\u2013637","journal-title":"Drug Metab Rev"},{"key":"2443_CR6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1124\/pr.110.003525","volume":"63","author":"FP Guengerich","year":"2011","unstructured":"Guengerich FP, Cheng Q (2011) Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology. Pharmacol Rev 63:684\u2013699","journal-title":"Pharmacol Rev"},{"key":"2443_CR7","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.taap.2004.12.022","volume":"207","author":"M Karlgren","year":"2005","unstructured":"Karlgren M, Miura SI, Ingelman-Sundberg M (2005) Novel extrahepatic cytochrome P450s. Toxicol Appl Pharmacol 207:S57\u2013S61","journal-title":"Toxicol Appl Pharmacol"},{"key":"2443_CR8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2004.01.110","volume":"315","author":"M Karlgren","year":"2004","unstructured":"Karlgren M, Backlund M, Johansson I, Oscarson M, Ingelman-Sundberg M (2004) Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1. Biochem Biophys Res Commun 315:679\u2013685","journal-title":"Biochem Biophys Res Commun"},{"key":"2443_CR9","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1074\/jbc.M311830200","volume":"279","author":"SS Chuang","year":"2004","unstructured":"Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, Amad M, White JA, Petkovich M, Jones G, Korczak B (2004) CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids. J Biol Chem 279:6305\u20136314","journal-title":"J Biol Chem"},{"key":"2443_CR10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0003-9861(02)00553-2","volume":"409","author":"DR Nelson","year":"2003","unstructured":"Nelson DR (2003) Comparison of P450s from human and fugu: 420 million years of vertebrate P450 evolution. Arch Biochem Biophys 409:18\u201324","journal-title":"Arch Biochem Biophys"},{"key":"2443_CR11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/1471-2164-11-643","volume":"11","author":"JV Goldstone","year":"2010","unstructured":"Goldstone JV, McArthur AG, Kubota A, Zanette J, Parente T, J\u00f6nsson ME, Nelson DR, Stegeman JJ (2010) Identification and developmental expression of the full complement of cytochrome P450 genes in Zebrafish. BMC Genom 11:643\u2013663","journal-title":"BMC Genom"},{"key":"2443_CR12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00239-010-9402-7","volume":"72","author":"N Kirischian","year":"2011","unstructured":"Kirischian N, McArthur AG, Jesuthasan C, Krattenmacher B, Wilson JY (2011) Phylogenetic and functional analysis of the vertebrate cytochrome p450 2 family. J Mol Evol 72:56\u201371","journal-title":"J Mol Evol"},{"key":"2443_CR13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cbpc.2010.11.006","volume":"153","author":"A Kubota","year":"2011","unstructured":"Kubota A, Stegeman JJ, Goldstone JV, Nelson DR, Kim EY, Tanabe S, Iwata H (2011) Cytochrome P450 CYP2 genes in the common cormorant: evolutionary relationships with 130 diapsid CYP2 clan sequences and chemical effects on their expression. Comp Biochem Physiol C Toxicol Pharmacol 153:280\u2013289","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"2443_CR14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ydbio.2006.08.066","volume":"300","author":"JV Goldstone","year":"2006","unstructured":"Goldstone JV, Hamdoun A, Cole BJ, Howard-Ashby M, Nebert DW, Scally M, Dean M, Epel D, Hahn ME, Stegeman JJ (2006) The chemical defensome: environmental sensing and response genes in the Strongylocentrotus purpuratus genome. Dev Biol 300:366\u2013384","journal-title":"Dev Biol"},{"key":"2443_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","volume":"14","author":"DR Nelson","year":"2004","unstructured":"Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW (2004) Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1\u201318","journal-title":"Pharmacogenetics"},{"key":"2443_CR16","doi-asserted-by":"crossref","first-page":"38084","DOI":"10.1074\/jbc.M307028200","volume":"278","author":"JB Cheng","year":"2003","unstructured":"Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW (2003) De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J Biol Chem 278:38084\u201338093","journal-title":"J Biol Chem"},{"key":"2443_CR17","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.bbagen.2015.03.014","volume":"1850","author":"L Ducassou","year":"2015","unstructured":"Ducassou L, Jonasson G, Dhers L, Pietrancosta N, Ramassamy B, Xu-Li Y, Loriot MA, Beaune P, Bertho G, Lombard M, Mansuy D, Andr\u00e9 F, Boucher JL (2015) Expression in yeast, new substrates, and construction of a first 3D model of human orphan cytochrome P450 2U1: interpretation of substrate hydroxylation regioselectivity from docking studies. Biochim Biophys Acta 1850:1426\u20131437","journal-title":"Biochim Biophys Acta"},{"key":"2443_CR18","volume-title":"Study of a human orphan cytochrome P450, CYP2U1. PhD-Thesis","author":"L Ducassou","year":"2012","unstructured":"Ducassou L (2012) Study of a human orphan cytochrome P450, CYP2U1. PhD-Thesis. University Paris Descartes, France"},{"key":"2443_CR19","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389\u20133402","journal-title":"Nucleic Acids Res"},{"key":"2443_CR20","doi-asserted-by":"crossref","first-page":"10476","DOI":"10.1074\/jbc.M114.550004","volume":"289","author":"M Siller","year":"2014","unstructured":"Siller M, Goyal S, Yoshimoto FK, Xiao Y, Wei S, Guengerich FP (2014) Oxidation of endogenous N-arachidonoylserotonin by human cytochrome P450 2U1. J Biol Chem 289:10476\u201310487","journal-title":"J Biol Chem"},{"key":"2443_CR21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.abb.2005.02.001","volume":"436","author":"D Choudhary","year":"2005","unstructured":"Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB (2005) Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch Biochem Biophys 436:50\u201361","journal-title":"Arch Biochem Biophys"},{"key":"2443_CR22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/FPC.0b013e32810f2e58","volume":"17","author":"I Bi\u00e8che","year":"2007","unstructured":"Bi\u00e8che I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, de Waziers I (2007) Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 17:731\u2013742","journal-title":"Pharmacogenet Genomics"},{"key":"2443_CR23","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1124\/dmd.109.027011","volume":"37","author":"F Dutheil","year":"2009","unstructured":"Dutheil F, Dauchy S, Diry M, Sazdovitch V, Cloarec O, Mellott\u00e9e L, Bi\u00e8che I, Ingelman-Sundberg M, Flinois JP, de Waziers I, Beaune P, Decl\u00e8ves X, Duyckaerts C, Loriot MA (2009) Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos 37:1528\u20131538","journal-title":"Drug Metab Dispos"},{"key":"2443_CR24","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.bcp.2008.11.001","volume":"77","author":"S Dauchy","year":"2009","unstructured":"Dauchy S, Miller F, Couraud PO, Weaver RJ, Weksler B, Romero IA, Scherrmann JM, De Waziers I, Decl\u00e8ves X (2009) Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC\/D3 human cerebral microvascular endothelial cells. Biochem Pharmacol 77:897\u2013909","journal-title":"Biochem Pharmacol"},{"key":"2443_CR25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.taap.2005.10.003","volume":"213","author":"L Du","year":"2006","unstructured":"Du L, Neis MM, Ladd PA, Lanza DL, Yost GS, Keeney DS (2006) Effects of the differentiated keratinocyte phenotype on expression levels of CYP1-4 family genes in human skin cells. Toxicol Appl Pharmacol 213:135\u2013144","journal-title":"Toxicol Appl Pharmacol"},{"key":"2443_CR26","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/mp200129p","volume":"8","author":"R Shawahna","year":"2011","unstructured":"Shawahna R, Uchida Y, Decl\u00e8ves X, Ohtsuki S, Yousif S, Dauchy S, Jacob A, Chassoux F, Daumas-Duport C, Couraud PO, Terasaki T, Scherrmann JM (2011) Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm 8:1332\u20131341","journal-title":"Mol Pharm"},{"key":"2443_CR27","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/138920011798357024","volume":"12","author":"X Decleves","year":"2011","unstructured":"Decleves X, Jacob A, Yousif S, Shawahna R, Potin S, Scherrmann JM (2011) Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier. Curr Drug Metab 12:732\u2013741","journal-title":"Curr Drug Metab"},{"key":"2443_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.plefa.2013.06.008","volume":"89","author":"YB Jarrar","year":"2013","unstructured":"Jarrar YB, Cho SA, Oh KS, Kim DH, Shin JG, Lee SJ (2013) Identification of cytochrome P450s involved in the metabolism of arachidonic acid in human platelets. Prostaglandins Leukot Essent Fatty Acids 89:227\u2013234","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2443_CR29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11626-013-9633-1","volume":"49","author":"YB Jarrar","year":"2013","unstructured":"Jarrar YB, Shin JG, Lee SJ (2013) Expression of arachidonic acid-metabolizing cytochrome P450s in human megakaryocytic Dami cells. In Vitro Cell Dev Biol Anim 49:492\u2013500","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"2443_CR30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/dmd.109.029249","volume":"38","author":"S Ellero","year":"2010","unstructured":"Ellero S, Chakhtoura G, Barreau C, Langou\u00ebt S, Benelli C, Penicaud L, Beaune P, de Waziers I (2010) Xenobiotic-metabolizing cytochromes p450 in human white adipose tissue: expression and induction. Drug Metab Dispos 38:679\u2013686","journal-title":"Drug Metab Dispos"},{"key":"2443_CR31","doi-asserted-by":"crossref","first-page":"e39006","DOI":"10.1371\/journal.pone.0039006","volume":"7","author":"KC Wu","year":"2012","unstructured":"Wu KC, Cui JY, Klaassen CD (2012) Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver. PLoS One 7:e39006","journal-title":"PLoS One"},{"key":"2443_CR32","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1248\/bpb.b16-00279","volume":"39","author":"N Moriya","year":"2016","unstructured":"Moriya N, Kataoka H, Nishikawa JI, Kugawa F (2016) Identification of candidate target Cyp genes for microRNAs whose expression is altered by PCN and TCPOBOP, representative ligands of PXR and CAR. Biol Pharm Bull 39:1381\u20131386","journal-title":"Biol Pharm Bull"},{"key":"2443_CR33","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3109\/00498254.2015.1040102","volume":"45","author":"F Toselli","year":"2015","unstructured":"Toselli F, de Waziers I, Dutheil M, Vincent M, Wilce PA, Dodd PR, Beaune P, Loriot MA, Gillam E (2015) Gene expression profiling of cytochromes P450, ABC transporters and their principal transcription factors in the amygdala and prefrontal cortex of alcoholics, smokers and drug-free controls by qRT-PCR. Xenobiotica 45:1129\u20131137","journal-title":"Xenobiotica"},{"key":"2443_CR34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/acer.12697","volume":"39","author":"F Toselli","year":"2015","unstructured":"Toselli F, Booth Depaz IM, Worrall S, Etheridge N, Dodd PR, Wilce PA, Gillam EM (2015) Expression of CYP2E1 and CYP2U1 proteins in amygdala and prefrontal cortex: influence of alcoholism and smoking. Alcohol Clin Exp Res 39:790\u2013797","journal-title":"Alcohol Clin Exp Res"},{"key":"2443_CR35","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1158\/1078-0432.CCR-04-1848","volume":"11","author":"M Kumarakulasingham","year":"2005","unstructured":"Kumarakulasingham M, Rooney PH, Dundas SR, Telfer C, Melvin WT, Curran S, Murray GI (2005) Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res 11:3758\u20133765","journal-title":"Clin Cancer Res"},{"key":"2443_CR36","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1158\/1078-0432.CCR-05-0466","volume":"11","author":"D Downie","year":"2005","unstructured":"Downie D, McFadyen MC, Rooney PH, Cruickshank ME, Parkin DE, Miller ID, Telfer C, Melvin WT, Murray GI (2005) Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res 11:7369\u20137375","journal-title":"Clin Cancer Res"},{"key":"2443_CR37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2559.2010.03606.x","volume":"57","author":"GI Murray","year":"2010","unstructured":"Murray GI, Patimalla S, Stewart KN, Miller ID, Heys SD (2010) Profiling the expression of cytochrome P450 in breast cancer. Histopathology 57:202\u2013211","journal-title":"Histopathology"},{"key":"2443_CR38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/SHK.0b013e31829de02f","volume":"40","author":"HM Brandfellner","year":"2013","unstructured":"Brandfellner HM, Ruparel SB, Gelfond JA, Hargreaves KM (2013) Major blunt trauma evokes selective upregulation of oxidative enzymes in circulating leukocytes. Shock 40:182\u2013187","journal-title":"Shock"},{"key":"2443_CR39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.plefa.2010.06.005","volume":"83","author":"A Devos","year":"2010","unstructured":"Devos A, Lino Cardenas CL, Glowacki F, Engels A, Lo-Guidice JM, Chevalier D, Allorge D, Broly F, Cauffiez C (2010) Genetic polymorphism of CYP2U1, a cytochrome P450 involved in fatty acids hydroxylation. Prostaglandins Leukot Essent Fatty Acids 83:105\u2013110","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2443_CR40","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biochi.2009.12.007","volume":"92","author":"J Leclerc","year":"2010","unstructured":"Leclerc J, Tournel G, Courcot-Ngoubo Ngangue E, Pottier N, Lafitte JJ, Jaillard S, Mensier E, Lhermitte M, Broly F, Lo-Guidice JM (2010) Profiling gene expression of whole cytochrome P450 superfamily in human bronchial and peripheral lung tissues: differential expression in non-small cell lung cancers. Biochimie 92:292\u2013306","journal-title":"Biochimie"},{"key":"2443_CR41","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ajhg.2012.11.001","volume":"91","author":"C Tesson","year":"2012","unstructured":"Tesson C, Nawara M, Salih MA, Rossignol R, Zaki MS, Al Balwi M, Schule R, Mignot C, Obre E, Bouhouche A, Santorelli FM, Durand CM, Oteyza AC, El-Hachimi KH, Al Drees A, Bouslam N, Lamari F, Elmalik SA, Kabiraj MM, Seidahmed MZ, Esteves T, Gaussen M, Monin ML, Gyapay G, Lechner D, Gonzalez M, Depienne C, Mochel F, Lavie J, Schols L, Lacombe D, Yahyaoui M, Al Abdulkareem I, Zuchner S, Yamashita A, Benomar A, Goizet C, Durr A, Gleeson JG, Darios F, Brice A, Stevanin G (2012) Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia. Am J Hum Genet 91:1051\u20131064","journal-title":"Am J Hum Genet"},{"key":"2443_CR42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00415-013-7206-6","volume":"261","author":"A Citterio","year":"2014","unstructured":"Citterio A, Arnoldi A, Panzeri E, D\u2019Angelo MG, Filosto M, Dilena R, Arrigoni F, Castelli M, Maghini C, Germiniasi C, Menni F, Martinuzzi A, Bresolin N, Bassi MT (2014) Mutations in CYP2U1, DDHD2 and GBA2 genes are rare causes of complicated forms of hereditary spastic paraparesis. J Neurol 261:373\u2013381","journal-title":"J Neurol"},{"key":"2443_CR43","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejpn.2016.02.001","volume":"20","author":"M Masciullo","year":"2016","unstructured":"Masciullo M, Tessa A, Perazza S, Santorelli FM, Perna A, Silvestri G (2016) Hereditary spastic paraplegia: novel mutations and expansion of the phenotype variability in SPG56. Eur J Paediatr Neurol 20:444\u2013448","journal-title":"Eur J Paediatr Neurol"},{"key":"2443_CR44","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00415-016-8066-7","volume":"263","author":"L Leonardi","year":"2016","unstructured":"Leonardi L, Ziccardi L, Marcotulli C, Rubegni A, Longobardi A, Serrao M, Storti E, Pierelli F, Tessa A, Parisi V, Santorelli FM, Carlo C (2016) Pigmentary degenerative maculopathy as prominent phenotype in an Italian SPG56\/CYP2U1 family. J Neurol 263:781\u2013783","journal-title":"J Neurol"},{"key":"2443_CR45","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejpn.2016.05.013","volume":"20","author":"A Kariminejad","year":"2016","unstructured":"Kariminejad A, Sch\u00f6ls L, Sch\u00fcle R, Tonekaboni SH, Abolhassani A, Fadaee M, Rosti RO, Gleeson JG (2016) CYP2U1 mutations in two Iranian patients with activity induced dystonia, motor regression and spastic paraplegia. Eur J Paediatr Neurol 20:782\u2013787","journal-title":"Eur J Paediatr Neurol"},{"key":"2443_CR46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12931-014-0134-x","volume":"15","author":"B Thyagarajan","year":"2014","unstructured":"Thyagarajan B, Wojczynski M, Minster RL, Sanders J, Barral S, Christiansen L, Barr RG, Newman A, CHARGE consortium, SpiroMeta consortium (2014) Genetic variants associated with lung function: the long life family study. Respir Res 15:134\u2013142","journal-title":"Respir Res"},{"key":"2443_CR47","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1016\/j.bbagen.2016.07.018","volume":"1861","author":"L Dhers","year":"2016","unstructured":"Dhers L, Pietrancosta N, Ducassou L, Ramassamy B, Dairou J, Jaouen M, Andr\u00e9 F, Mansuy D, Boucher JL (2016) Spectral and 3D model studies of the interaction of orphan human cytochrome P450 2U1 with substrates and ligands. Biochim Biophys Acta 1861:3144\u20133153","journal-title":"Biochim Biophys Acta"},{"key":"2443_CR48","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/j.1552-4604.1964.tb00372.x","volume":"4","author":"WB Abrams","year":"1964","unstructured":"Abrams WB, Pocelinko R, Klausner M, Hanauer L, Whitman EN (1964) Clinical pharmacological studies with debrisoquin sulfate, a new antihypertensive agent. J New Drugs 4:268\u2013283","journal-title":"J New Drugs"},{"key":"2443_CR49","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/sj.clpt.6100050","volume":"81","author":"U Fuhr","year":"2007","unstructured":"Fuhr U, Jetter A, Kirchheiner J (2007) Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the \u201ccocktail\u201d approach. Clin Pharmacol Ther 81:270\u2013283","journal-title":"Clin Pharmacol Ther"},{"key":"2443_CR50","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/elps.1150181025","volume":"18","author":"M Lanz","year":"1997","unstructured":"Lanz M, Theurillat R, Thormann W (1997) Characterization of stereoselectivity and genetic polymorphism of the debrisoquine hydroxylation in man via analysis of urinary debrisoquine and 4-hydroxydebrisoquine by capillary electrophoresis. Electrophoresis 18:1875\u20131881","journal-title":"Electrophoresis"},{"key":"2443_CR51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/004982500237622","volume":"30","author":"T Lightfoot","year":"2000","unstructured":"Lightfoot T, Ellis SW, Mahling J, Ackland MJ, Blaney FE, Bijloo GJ, De Groot MJ, Vermeulen NP, Blackburn GM, Lennard MS, Tucker GT (2000) Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modelling. Xenobiotica 30:219\u2013233","journal-title":"Xenobiotica"},{"key":"2443_CR52","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/bj3450565","volume":"345","author":"SW Ellis","year":"2000","unstructured":"Ellis SW, Hayhurst GP, Lightfoot T, Smith G, Harlow J, Rowland-Yeo K, Larsson C, Mahling J, Lim CK, Wolf CR, Blackburn MG, Lennard MS, Tucker GT (2000) Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6. Biochem J 345:565\u2013571","journal-title":"Biochem J"},{"key":"2443_CR53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/03602537508993762","volume":"4","author":"CR Kinsolving","year":"1975","unstructured":"Kinsolving CR, Munro NL (1975) The objective and timing of drug disposition studies, appendix V. A comparison of the bioavailability of three dosage forms of terfenadine. Drug Metab Rev 4:285\u2013290","journal-title":"Drug Metab Rev"},{"key":"2443_CR54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.abb.2007.03.028","volume":"464","author":"P Lafite","year":"2007","unstructured":"Lafite P, Dijols S, Zeldin DC, Dansette PM, Mansuy D (2007) Selective, competitive and mechanism-based inhibitors of human cytochrome P450 2J2. Arch Biochem Biophys 464:155\u2013168","journal-title":"Arch Biochem Biophys"},{"key":"2443_CR55","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1021\/bi700876a","volume":"46","author":"P Lafite","year":"2007","unstructured":"Lafite P, Andr\u00e9 F, Zeldin DC, Dansette PM, Mansuy D (2007) Unusual regioselectivity and active site topology of human cytochrome P450 2J2. Biochemistry 46:10237\u201310247","journal-title":"Biochemistry"},{"key":"2443_CR56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0090-9556(25)07393-3","volume":"21","author":"CH Yun","year":"1993","unstructured":"Yun CH, Okerholm RA, Guengerich FP (1993) Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab Dispos 21:403\u2013409","journal-title":"Drug Metab Dispos"},{"key":"2443_CR57","doi-asserted-by":"crossref","first-page":"17227","DOI":"10.1074\/jbc.M802180200","volume":"283","author":"GA Schoch","year":"2008","unstructured":"Schoch GA, Yano JK, Sansen S, Dansette PM, Stout CD, Johnson EF (2008) Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid. J Biol Chem 283:17227\u201317237","journal-title":"J Biol Chem"},{"key":"2443_CR58","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbagen.2006.07.005","volume":"1770","author":"V Cojocaru","year":"2007","unstructured":"Cojocaru V, Winn PJ, Wade RC (2007) The ins and outs of cytochrome P450s. Biochim Biophys Acta 1770:390\u2013401","journal-title":"Biochim Biophys Acta"},{"key":"2443_CR59","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/bab.1074","volume":"60","author":"X Yu","year":"2013","unstructured":"Yu X, Cojocaru V, Wade RC (2013) Conformational diversity and ligand tunnels of mammalian cytochrome P450s. Biotechnol Appl Biochem 60:134\u2013145","journal-title":"Biotechnol Appl Biochem"},{"key":"2443_CR60","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/prot.21778","volume":"71","author":"W Li","year":"2008","unstructured":"Li W, Tang Y, Liu H, Cheng J, Zhu W, Jiang H (2008) Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking. Prot Struct Func Genet 71:938\u2013949","journal-title":"Prot Struct Func Genet"},{"key":"2443_CR61","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1016\/S0021-9258(18)34823-3","volume":"257","author":"JH Dawson","year":"1982","unstructured":"Dawson JH, Andersson LA, Sono M (1982) Spectroscopic investigations of ferric cytochrome P-450-CAM ligand complexes. J Biol Chem 257:3606\u20133617","journal-title":"J Biol Chem"},{"key":"2443_CR62","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1038\/ncomms6835","volume":"5","author":"NK Biswas","year":"2014","unstructured":"Biswas NK, Das S, Maitra A, Sarin R, Majumder PP (2014) Somatic mutations in arachidonic acid metabolism pathway genes enhance oral cancer post-treatment disease-free survival. Nat Commun 5:5835","journal-title":"Nat Commun"},{"key":"2443_CR63","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/bbrc.1998.8874","volume":"248","author":"T Bisogno","year":"1998","unstructured":"Bisogno T, Melck D, De Petrocellis L, Bobrov M, Gretskaya NM, Bezuglov VV, Sitachitta N, Gerwick WH, Di Marzo V (1998) Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 248:515\u2013522","journal-title":"Biochem Biophys Res Commun"},{"key":"2443_CR64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00401-013-1115-8","volume":"126","author":"JK Fink","year":"2013","unstructured":"Fink JK (2013) Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol 126:307\u2013328","journal-title":"Acta Neuropathol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2443-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-016-2443-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2443-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T10:36:46Z","timestamp":1749897406000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-016-2443-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,12]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["2443"],"URL":"https:\/\/doi.org\/10.1007\/s00018-016-2443-3","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,12]]}}}